Corvus Pharmaceuticals (CRVS) Return on Assets [ROA] (2016 - 2026)
Corvus Pharmaceuticals' Return on Assets [ROA] was -19.41% in Q2 2026, up 27.74 percentage points from -47.14% a year earlier but down 10.28 percentage points from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Return on Assets [ROA] (2016 - 2026) Analysis & Trends
For FY2023, Return on Assets [ROA] at Corvus Pharmaceuticals came in at -38.36%, down 2.44 percentage points from FY2022.
- Return on Assets [ROA] shows a five-year change of +5.72 percentage points (FY2018 to FY2023).
- In earlier years, Return on Assets [ROA] was -35.92% in FY2022 (+3.72 pp), -39.64% in FY2021 (+11.46 pp), -51.10% in FY2020 (-4.86 pp) and -46.24% in FY2019 (-2.17 pp).
- Quarterly Return on Assets [ROA] has moved between -88.23% (Q3 2024) and -9.13% (Q1 2026) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in three of the last six quarters, with an average year-over-year change of +8.55 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2026 (a gain of 42.96 percentage points); the worst was Q3 2024 (a drop of 48.51 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | -19.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.41% |
| Mar 31, 2026 | -9.13% |
| Sep 30, 2025 | -48.54% |
| Jun 30, 2025 | -47.14% |
| Mar 31, 2025 | -52.09% |
| Sep 30, 2024 | -88.23% |
| Jun 30, 2024 | -38.28% |
| Mar 31, 2024 | -50.36% |
| Dec 31, 2023 | -44.65% |
| Sep 30, 2023 | -39.72% |
| Jun 30, 2023 | -49.82% |
| Mar 31, 2023 | -48.48% |
| Dec 31, 2022 | -42.95% |
| Sep 30, 2022 | -38.62% |
| Jun 30, 2022 | -31.15% |
| Mar 31, 2022 | -32.80% |
| Dec 31, 2021 | -33.78% |
| Sep 30, 2021 | -36.47% |
| Jun 30, 2021 | -38.83% |
| Mar 31, 2021 | -42.89% |
API Access
Corvus Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();